GeneDx Ownership | Who Owns GeneDx?


OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary


GeneDx is owned by 70.04% institutional investors, 12.32% insiders, and 17.64% retail investors. Corvex management lp is the largest institutional shareholder, holding 10.70% of WGS shares.

WGS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGeneDx70.04%12.32%17.64%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryHealthcare Information Services Stocks 33.19%12.66%54.15%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corvex management lp3.06M10.70%$329.54M
Casdin capital3.01M10.52%$323.99M
Blackrock funding, inc. /de1.56M5.42%$202.91M
Goldman sachs group1.22M4.24%$158.74M
Vanguard group1.19M4.13%$154.65M
Franklin resources1.09M3.80%$142.15M
Westfield capital management co lp1.02M3.54%$132.44M
Oracle investment management922.45K3.23%$85.15M
Summit partners public asset management823.57K2.88%$88.73M
William blair investment management809.21K2.81%$105.25M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management922.45K58.40%$85.15M
Casdin capital3.01M27.01%$323.99M
Alamea verwaltungs gmbh195.99K14.43%$21.12B
Corvex management lp3.06M10.93%$329.54M
Gagnon advisors127.06K8.45%$13.69M
Science & technology partners224.07K6.73%$24.14M
Gagnon securities269.07K5.82%$28.99M
Zweig-dimenna associates597.83K4.83%$77.75M
Palisades investment partners87.16K4.28%$11.34M
Legal advantage investments59.65K3.59%$7.76M

Top Buyers

HolderShares% AssetsChange
Westfield capital management co lp1.02M0.55%474.17K
Franklin resources1.09M0.03%411.61K
Fmr503.31K0.00%339.99K
Price t rowe associates inc /md/331.41K0.00%316.35K
D. e. shaw294.52K0.02%263.13K

Top Sellers

HolderShares% AssetsChange
Pentwater capital management lp425.00K0.26%-795.00K
Millennium management58.80K0.00%-515.63K
Casdin capital3.01M27.01%-500.00K
Fred alger management357.30K0.15%-463.22K
Blackstone---420.71K

New Positions

HolderShares% AssetsChangeValue
Capital research global investors122.67K0.00%122.67K$15.95M
Axiom investors llc /de68.86K0.08%68.86K$8.96M
Norges bank68.00K0.00%68.00K$8.84M
Axa investment managers58.18K0.02%58.18K$6.27M
Renaissance57.32K0.01%57.32K$7.45M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Assetmark-1.00
Gps wealth strategies group-1.00
Mai capital management-1.00
Mather group, llc.-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025233-19.93%20,170,201-32.99%700.63%118-24.36%78-8.24%
Sep 30, 202528216.53%29,207,814-0.14%1020.98%1513.42%8450.00%
Jun 30, 20252481.64%31,311,68210.33%1091.08%146-0.68%60-1.64%
Mar 31, 202524215.24%28,417,95020.78%1001.34%144-4.64%6272.22%
Dec 31, 202419836.55%21,822,46915.86%801.67%14145.36%3332.00%

Recent Insider Transactions


DateNameRoleActivityValue
Mar 09, 2026Feeley Kevin CHIEF FINANCIAL OFFICERSell$111.05K
Mar 05, 2026Meister Keith A. Buy$155.53K
Mar 05, 2026Meister Keith A. Buy$2.40M
Mar 05, 2026Meister Keith A. Buy$4.95M
Mar 05, 2026Meister Keith A. Buy$3.84M

Insider Transactions Trends


DateBuySell
2026 Q11022
2025 Q4-43
2025 Q3-39
2025 Q2537
2025 Q1-30

WGS Ownership FAQ


Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 70.04%, followed by 12.32% insiders and 17.64% retail investors. The average institutional ownership in GeneDx's industry, Healthcare Information Services Stocks , is 33.19%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Corvex management lp (3.06M shares, 10.70%), Casdin capital (3.01M shares, 10.52%), and Blackrock funding, inc. /de (1.56M shares, 5.42%). Together, they hold 26.64% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Oracle investment management is GeneDx’s biggest shareholder by percentage of total assets invested, with 58.40% of its assets in 922.45K GeneDx shares, valued at 85.15M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools